Page 21234..1020..»

Archive for the ‘Crispr’ Category

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month High on Better-Than-Expected Earnings – AmericanBankingNEWS

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month High on Better-Than-Expected Earnings  AmericanBankingNEWS

More:
CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month High on Better-Than-Expected Earnings - AmericanBankingNEWS

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results – GlobeNewswire

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results  GlobeNewswire

Go here to see the original:
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire

CRISPR Therapeutics AG (CRSP) Moves 6.9% Higher: Will This Strength Last? – Yahoo Finance

CRISPR Therapeutics AG (CRSP) Moves 6.9% Higher: Will This Strength Last?  Yahoo Finance

Read the original here:
CRISPR Therapeutics AG (CRSP) Moves 6.9% Higher: Will This Strength Last? - Yahoo Finance

Advancements in RNA for HIV Treatment: CRISPR Cas9, mRNA Therapeutics, and Next-Generation Sequencing … – Medriva

Advancements in RNA for HIV Treatment: CRISPR Cas9, mRNA Therapeutics, and Next-Generation Sequencing ...  Medriva

See more here:
Advancements in RNA for HIV Treatment: CRISPR Cas9, mRNA Therapeutics, and Next-Generation Sequencing ... - Medriva

Intellia Therapeutics Charges Ahead: A Glimpse into the Future of CRISPR-Based Therapies – BNN Breaking

Intellia Therapeutics Charges Ahead: A Glimpse into the Future of CRISPR-Based Therapies  BNN Breaking

Read more:
Intellia Therapeutics Charges Ahead: A Glimpse into the Future of CRISPR-Based Therapies - BNN Breaking

The FDA Approved The First CRISPR-Based Therapy. What’s Next? – Science Friday

The FDA Approved The First CRISPR-Based Therapy. What's Next?  Science Friday

Originally posted here:
The FDA Approved The First CRISPR-Based Therapy. What's Next? - Science Friday

Using CRISPR technology, researchers succeed in growing tomatoes that consume less water without compromising yield – Phys.org

Using CRISPR technology, researchers succeed in growing tomatoes that consume less water without compromising yield  Phys.org

Read this article:
Using CRISPR technology, researchers succeed in growing tomatoes that consume less water without compromising yield - Phys.org

CRISPR-Cas9 gene-editing tool repairs defective T cells to treat rare hereditary disease – News-Medical.Net

CRISPR-Cas9 gene-editing tool repairs defective T cells to treat rare hereditary disease  News-Medical.Net

See the original post here:
CRISPR-Cas9 gene-editing tool repairs defective T cells to treat rare hereditary disease - News-Medical.Net

New CRISPR Technology Increases Recognition of Cancer Cells by the Immune System – Inside Precision Medicine

New CRISPR Technology Increases Recognition of Cancer Cells by the Immune System  Inside Precision Medicine

The rest is here:
New CRISPR Technology Increases Recognition of Cancer Cells by the Immune System - Inside Precision Medicine

Is CRISPR Therapeutics a Buy in the New Bull Market? – The Motley Fool

Is CRISPR Therapeutics a Buy in the New Bull Market?  The Motley Fool

Read more:
Is CRISPR Therapeutics a Buy in the New Bull Market? - The Motley Fool

Stocks Flashing Renewed Technical Strength: CRISPR Therapeutics – Investor’s Business Daily

Stocks Flashing Renewed Technical Strength: CRISPR Therapeutics  Investor's Business Daily

Originally posted here:
Stocks Flashing Renewed Technical Strength: CRISPR Therapeutics - Investor's Business Daily

AI at Davos, new CRISPR therapies and health tech’s bad marketing – Marketplace

AI at Davos, new CRISPR therapies and health tech's bad marketing  Marketplace

See the article here:
AI at Davos, new CRISPR therapies and health tech's bad marketing - Marketplace

FDA expands use of newly approved CRISPR therapy – Axios

FDA expands use of newly approved CRISPR therapy  Axios

See the original post here:
FDA expands use of newly approved CRISPR therapy - Axios

CRISPR-based therapy receives expanded approval for beta thalassemia – STAT

CRISPR-based therapy receives expanded approval for beta thalassemia  STAT

See original here:
CRISPR-based therapy receives expanded approval for beta thalassemia - STAT

CRISPR Therapeutics And Vertex’s CRISPR Breakthrough: How And Why They Got There First – Scrip

CRISPR Therapeutics And Vertex's CRISPR Breakthrough: How And Why They Got There First  Scrip

Continue reading here:
CRISPR Therapeutics And Vertex's CRISPR Breakthrough: How And Why They Got There First - Scrip

Pharmalittle: We’re reading about a CRISPR approval, selling meds directly to patients, and more – STAT

Pharmalittle: We're reading about a CRISPR approval, selling meds directly to patients, and more  STAT

See the original post:
Pharmalittle: We're reading about a CRISPR approval, selling meds directly to patients, and more - STAT

Here’s Why CRISPR Therapeutics Stock Rose 54% Last Year – The Motley Fool

Here's Why CRISPR Therapeutics Stock Rose 54% Last Year  The Motley Fool

Excerpt from:
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year - The Motley Fool

Vertex’s CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease – MedCity News

Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease  MedCity News

Read the rest here:
Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease - MedCity News

Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval – geneonline

Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval  geneonline

Link:
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval - geneonline

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024? – The Motley Fool

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?  The Motley Fool

See the article here:
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024? - The Motley Fool

First FDA-approved CRISPR-based gene therapy cleared for 2nd indication – LabPulse

First FDA-approved CRISPR-based gene therapy cleared for 2nd indication  LabPulse

See the original post:
First FDA-approved CRISPR-based gene therapy cleared for 2nd indication - LabPulse

CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY … – GlobeNewswire

CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY ...  GlobeNewswire

See the rest here:
CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY ... - GlobeNewswire

CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com – TheHealthSite

CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com  TheHealthSite

More:
CRISPR Gene Editing And Its Role In Hematology | TheHealthSite.com - TheHealthSite

Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution – STAT

Doudna institute hatches plan to 'cure hundreds of diseases' left behind by CRISPR revolution  STAT

More:
Doudna institute hatches plan to 'cure hundreds of diseases' left behind by CRISPR revolution - STAT

Discover the recent progress of nonviral delivery carriers for CRISPR/Cas9 systems – News-Medical.Net

Discover the recent progress of nonviral delivery carriers for CRISPR/Cas9 systems  News-Medical.Net

View post:
Discover the recent progress of nonviral delivery carriers for CRISPR/Cas9 systems - News-Medical.Net

Archives